Muscle Blood Flow Regulation in HFpEF

Description

Heart failure with preserved ejection (HFpEF) disproportionately affects Veterans and is the number one reason for hospital discharge in the VA Health Care System. Exercise intolerance is a common complication experienced by patients with HFpEF, perpetuating physical inactivity and accelerating disease progression. This research proposal aims to elucidate mechanisms responsible for inadequate skeletal muscle blood flow and exercise intolerance in patients with HFpEF compared with healthy controls as well as following 8 weeks of exercise training in patients with HFpEF only.

Conditions

HFpEF

Talk to us

Study Overview

On this page

Study Details

Study overview

Heart failure with preserved ejection (HFpEF) disproportionately affects Veterans and is the number one reason for hospital discharge in the VA Health Care System. Exercise intolerance is a common complication experienced by patients with HFpEF, perpetuating physical inactivity and accelerating disease progression. This research proposal aims to elucidate mechanisms responsible for inadequate skeletal muscle blood flow and exercise intolerance in patients with HFpEF compared with healthy controls as well as following 8 weeks of exercise training in patients with HFpEF only.

Mechanisms of Impaired Skeletal Muscle Blood Flow and Exercise Intolerance in Veterans With Heart Failure With Preserved Ejection Fraction: Efficacy of Knee Extensor Training

Muscle Blood Flow Regulation in HFpEF

Condition
HFpEF
Intervention / Treatment

-

Contacts and Locations

Salt Lake City

VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah, United States, 84148-0001

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18 years or older and able to give written informed consent
  • * New York Heart Association (NYHA) functional class II or III
  • * Left Ventricular Ejection Fraction (LVEF) \> 50%
  • * Plasma Brain Natriuretic Peptide (BNP) \>200 pg/mL or NT-proBNP 400 pg/mL at enrollment
  • * Prior EF of \<50%.
  • * NYHA Class IV or HF that cannot be stabilized on optimized pharmacotherapy
  • * Acute coronary syndrome, infiltrative cardiomyopathy, or myocarditis
  • * Patients with HFpEF secondary to significant uncorrected primary valvular disease (except mitral regurgitation secondary to left ventricular dysfunction)
  • * Orthopedic limitations that would prohibit knee-extensor exercise
  • * Women currently taking hormone replacement therapy (HRT) will be excluded from the proposed studies due to the direct vascular effects of HRT
  • * Women who are pregnant or may become pregnant, but the typical age of female patients with HFpEF will be postmenopausal
  • * Current smokers

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

VA Office of Research and Development,

Kanokwan Bunsawat, PhD, PRINCIPAL_INVESTIGATOR, VA Salt Lake City Health Care System, Salt Lake City, UT

Study Record Dates

2028-02-29